Actively Recruiting
De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
Led by University of Michigan · Updated on 2026-05-08
16
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Michigan
Lead Sponsor
A
Agency for Healthcare Research and Quality (AHRQ)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The trial focuses on patients undergoing low-risk surgeries such as breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair. It aims to evaluate how well a multi-level, multi-component strategy reduces unnecessary preoperative testing. This research is sponsored by the University of Michigan and involves multiple surgical quality collaborative sites in Michigan to improve care practices. The study uses an active de-implementation approach involving clinician education, decision aids, performance feedback, and pay-for-performance incentives. These interventions are delivered locally over a three-month active phase following an eight-week preparation, across six waves starting in 2025 and continuing through 2026. Each wave includes periods of usual care, preparation, intervention, and sustainment to assess the impact of these strategies. Participants will be involved through their surgical care at participating sites, with the study monitoring the number of unnecessary tests done within 30 days before surgery. The research also tracks spending related to episodes of care, intraoperative complications, and same-day surgery cancellations. Data will be collected during and after the intervention phases to measure the effectiveness of reducing low-value testing and improving surgical outcomes over the study period.
CONDITIONS
Brief Title
De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Patients undergoing breast lumpectomy, laparoscopic cholecystectomy, or inguinal hernia repair
- Sites with over 30% testing rates for at least one of the three index procedures
You will not qualify if you...
- None reported for this study population or sites involved in the trial activity or patient selection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants and clinical teams prepare for the de-implementation intervention, including usual care practices.
No additional visits required specifically for preparation
Duration - 3 months
Participants’ clinical teams implement behavioral strategies to reduce low-value testing, including education, decision support, evaluation, and feedback.
Regular visits as part of routine care; no extra visits required for the intervention
Duration - Ongoing after active intervention
Participants continue to be observed as the de-implementation strategies are maintained over time.
Visits as part of routine care
Trial Site Locations
Total: 1 location
1
University of Michigan and other Michigan Surgical Quality Collaborative sites
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
D
Dana Greene Jr., MPH
V
Valerie Gavrila
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
6
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here